Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure

Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure

Joern Kekow,1 Ulf Mueller-Ladner,2 Hendrik Schulze-Koops31Clinic of Rheumatology and Orthopedics, Otto-von-Guericke University of Magdeburg, Vogelsang-Gommern; 2Department of Rheumatology and Clinical Immunology, Kerckhoff Clinic, Bad Nauheim; 3Division of Rheumatology, University of Munich, Munich,...

Full description

Bibliographic Details
Main Authors: Kekow J, Mueller-Ladner U, Schulze-Koops H
Format: Article
Language:English
Published: Dove Medical Press 2012-07-01
Series:Biologics : Targets & Therapy
Online Access:http://www.dovepress.com/rituximab-is-more-effective-than-second-anti-tnf-therapy-in-rheumatoid-a10276

Internet

http://www.dovepress.com/rituximab-is-more-effective-than-second-anti-tnf-therapy-in-rheumatoid-a10276

Similar Items